South Korean telecommunications giant KT Corporation and US-based bioelectronics developer NeuroSigma have signed a memorandum of understanding to form a strategic partnership focused on developing and selling electronic therapies treating neurological and neuropsychological disorders, such as ADHD, depression and epilepsy.
WHY IT MATTERS
NeuroSigma developed the first US FDA-approved device-...
